3M Company

(New York Stock Exchange)
Back to all articles
Bearish -65

RBC downgrades 3M to underperform, says inflation and legal issues will hamper stock

AI-generated analysis

πŸ“‰ RBC Capital Markets downgraded 3M from 'Sector Perform' to 'Underperform' due to mounting operating and legal challenges.

πŸ’° Analyst Deane Dray slashed the price target for 3M shares from $199 to $166 per share.

πŸ“Š The new price target is nearly 8% below where 3M stock closed on Tuesday, Jan 5, 2022.

πŸ”₯ Inflation and supply chain pressures have exposed weaknesses in 3M's price/cost actions that are unlikely to be remedied soon.

βš–οΈ 3M faces worsening litigation risks related to PFAS chemicals and military hearing-loss claims.

πŸ’Έ The company is expected to take more legal reserves to address mounting liabilities.

πŸ“‰ Shares of 3M underperformed the broader market in 2021, trading near pre-pandemic levels.

πŸ“ˆ The S&P 500 gained roughly 40% in 2021 while 3M failed to keep pace.

⚠️ RBC warns that headline risk and legal issues will hamper the stock's recovery.

Risk Factors
  • RBC Capital Markets downgraded 3M from 'Sector Perform' to 'Underperform', signaling a lack of upside for the foreseeable future.
  • Analyst Deane Dray slashed the price target from $199 to $166 per share, indicating a bearish outlook on valuation.
  • Inflation and supply chain pressures have exposed fundamental weaknesses in 3M's pricing and cost management strategies.
  • The company faces worsening litigation risks related to PFAS chemicals and military hearing-loss claims.
  • RBC warns that 3M will likely have to take more legal reserves to address mounting liabilities, impacting earnings.
  • Shares of 3M underperformed the broader market in 2021, trading near pre-pandemic levels despite a 40% S&P 500 gain.
  • The new price target is nearly 8% below where the stock closed on Tuesday, Jan 5, 2022.
Full Analysis
RBC Capital Markets has downgraded 3M stock from 'Sector Perform' to 'Underperform,' citing significant headwinds expected in 2022. Analyst Deane Dray noted that the company faces mounting operating and legal challenges, with inflation and supply chain pressures exposing fundamental weaknesses in its pricing and cost management strategies. RBC slashed its price target for 3M shares from $199 to $166 per share, a move that places the new target nearly 8% below the stock's closing price on Tuesday. The industrial giant has underperformed the broader market throughout 2021, trading near pre-pandemic levels despite a roughly 40% gain for the S&P 500 during the same period. Beyond financial metrics, the downgrade highlights severe legal risks associated with PFAS chemicals and military hearing-loss litigation. RBC warns that the company's litigation outlook will deteriorate before improving, likely necessitating increased legal reserves to address these mounting issues, which could further impact future earnings and stock performance.